Skip to main content
. Author manuscript; available in PMC: 2010 Jun 21.
Published in final edited form as: Int J Radiat Oncol Biol Phys. 2007 Sep 14;70(1):2–13. doi: 10.1016/j.ijrobp.2007.06.039

Fig. 3.

Fig. 3

Example of fluorine-18–labeled fluoromisonidazole (18F-FMISO) positron emission tomography (PET)–guided intensity-modulated radiotherapy (IMRT) plan for locoregionally advanced supraglottic carcinoma. (a) Axial comparison of original clinical plan (a-1) and 18F-FMISO PET–guided IMRT plan (a-2). (b) Sagittal view of 18F-FMISO PET–guided IMRT plan. (c) Coronal view of 18F-FMISO PET–guided IMRT plan.